Author:
Gong Inna Y.,Verma Sunil,Yan Andrew T.,Ko Dennis T.,Earle Craig C.,Tomlinson George A.,Trudeau Maureen E.,Krahn Murray D.,Krzyzanowska Monika K.,Brezden-Masley Christine B.,Gavura Scott,Peacock Stuart,Chan Kelvin K. W.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M et al (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365(14):1273–1283
2. Moja L, Tagliabue L, Balduzzi S, Parmelli E, Pistotti V, Guarneri V, D’Amico R (2012) Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev 4:CD006243
3. Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53(24):2231–2247
4. Truong J, Yan AT, Cramarossa G, Chan KK (2014) Chemotherapy-induced cardiotoxicity: detection, prevention, and management. Can J Cardiol 30(8):869–878
5. de Azambuja E, Procter MJ, van Veldhuisen DJ, Agbor-Tarh D, Metzger-Filho O, Steinseifer J, Untch M, Smith IE, Gianni L, Baselga J et al (2014) Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01). J Clin Oncol Off J Am Soc Clin Oncol 32(20):2159–2165
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献